Research paper
Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy

https://doi.org/10.1016/0960-8966(93)90042-IGet rights and content

Abstract

We have analysed the results of clinical assessment, X-inactivation status, deletion screening and dystrophin analysis in eight manifesting carriers of Duchenne and Becker muscular dystrophy (DMD and BMD). Only two had a prior family history of X-linked muscle disease, all had normal karyotypes and none were twins. Presentation varied from 2 to 25 yr and progression varied from a DMD-like severity to a very mild BMD-like course. In one girl the initial symptoms were restricted to learning difficulties. Where methods for assessing X-inactivation were informative, three patients showed an abnormal pattern. However, in one patient, the obligate carrier daughter of a BMD patient who had presented at the age of 2 yr, X-inactivation appeared normal in lymphocytes and muscle. While dystrophin analysis seems to be reliable in identifying manifesting carriers of DMD and BMD, the relationship between X-inactivation status, dystrophin analysis and phenotype is not simple.

References (39)

  • P.N. Ray et al.

    Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy

    Nature

    (1985)
  • M.R. Gomez et al.

    Failure of inactivation of Duchenne dystrophy X-chromosome in one of female identical twins

    Neurology

    (1977)
  • J.G. Chutkow et al.

    Monozygotic female twin carriers discordant for the clinical manifestations of Duchenne muscular dystrophy

    Neurology

    (1987)
  • E. Bonilla et al.

    Partial dystrophin deficiency in monozygous twin carriers of the Duchenne gene discordant for clinical myopathy

    Neurology

    (1990)
  • J. Burn et al.

    Duchenne muscular dystrophy in one of monozygotic twin girls

    J Med Genet

    (1986)
  • C.S. Richards et al.

    Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy

    Am J Hum Genet

    (1990)
  • K.M.D. Bushby et al.

    The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. 1. Natural history

    J Neurol

    (1993)
  • D. Weschler

    Manual for the Weschler Intelligence Scale for Children (Revised)

    (1974)
  • E.B. Weibel et al.

    Practical stereological methods for morphometric cytology

    J Cell Biol

    (1966)
  • Cited by (60)

    • Retinal dystrophins and the retinopathy of Duchenne muscular dystrophy

      2023, Progress in Retinal and Eye Research
      Citation Excerpt :

      Most of the male patients receive the defective gene from their mother, but one third of cases are caused by de novo mutations (Zatz et al., 1977). Heterozygous female carriers can show disease manifestations that may involve the muscle, the central nervous system, and/or the cardiac function (Bushby et al., 1993; Fitzgerald et al., 1999; Ishizaki et al., 2018; Lim et al., 2020; Mercier et al., 2013; Papa et al., 2016). However, because this is an allelic X-linked recessive genetic disease, estimates of frequency generally do not include affected females or female carriers.

    • Neuropsychological and behavioral profile in a cohort of Becker muscular dystrophy pediatric patients

      2022, Neuromuscular Disorders
      Citation Excerpt :

      Indeed, one of the most common (50% of general population) neurodevelopmental disorder in children with DMD is attention deficit hyperactivity disorder (ADHD) [4–6,9–13]. In BMD patients the cognitive functioning is usually spared whereas neurodevelopmental or behavioral comorbidities (like autistic and or inattention/hyperactivity symptoms), learning disabilities (difficulties in reading, spelling and arithmetic) and language–speech disorders are often observed [7,14,15]. In the BMD population no clear correlation between intellectual abilities and site of mutation has been found so far, but recently emotional symptoms such as anxiety were noted more frequently among patients with mutations upstream of exon 30 while other symptoms did not differ when considering mutation sites [16].

    • Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing

      2020, International Journal of Cardiology
      Citation Excerpt :

      Female carriers should theoretically be spared from phenotypic disease given the presence of a normal DMD gene on their second X-chromosome; however, they have long been reported to demonstrate some manifestations of similar dystrophin-deficient disease. Muscle weakness, abnormal gait, fatigue and cardiac involvement have all been reported [18]. Additionally, there are overtly manifesting young female carriers who present with onset and progression of disease like affected boys that offer evidence of clinical impacts of having one abnormal gene [19].

    View all citing articles on Scopus
    View full text